Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation

Clinical trial NCT05365672 · RECRUITING

Trial details

NCT number: NCT05365672
Sponsor: TolerogenixX GmbH
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Transplantation

Start date: 2022-05-04
Primary completion: 2026-12-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.